Sidney Kimmel Cancer Center at Thomas Jefferson University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Phase 1

Completed

Conditions: Stage IIB Prostate Cancer
Prostate Adenocarcinoma
Stage IV Prostate Cancer
Stage III Prostate Cancer

Interventions: Radiation: Copper Cu 64 TP3805
Procedure: Positron Emission Tomography
Procedure: Computed Tomography
Procedure: Radical Prostatectomy
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-11-13

Last Posted Date: 2016-10-21

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 25

Registration Number: NCT02603965

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer

Not Applicable

Withdrawn

Conditions: Malignant Neoplasm
Current Smoker

Interventions: Other: Tobacco Cessation Counseling
Other: Support Group Therapy
Other: Quality-of-Life Assessment

First Posted Date: 2015-10-29

Last Posted Date: 2016-10-19

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Registration Number: NCT02591433

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia

Phase 2

Completed

Conditions: Recurrent Adult Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia
Untreated Adult Acute Myeloid Leukemia

Interventions: Drug: Sirolimus
Drug: Mitoxantrone
Drug: Etoposide
Drug: Cytarabine

First Posted Date: 2015-10-22

Last Posted Date: 2023-10-10

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 39

Registration Number: NCT02583893

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

Not Applicable

Completed

Conditions: Skin Basal Cell Carcinoma

Interventions: Procedure: Therapeutic Conventional Surgery

First Posted Date: 2015-10-19

Last Posted Date: 2018-04-25

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 179

Registration Number: NCT02579551

Locations: 🇺🇸
Thomas Jefferson Univeristy, Philadelphia, Pennsylvania, United States

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2

Terminated

Conditions: Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Malignant Ovarian Endometrioid Tumor
Malignant Ovarian Serous Tumor
Recurrent Fallopian Tube Carcinoma

Interventions: Drug: Topotecan Hydrochloride
Drug: Acetylcysteine

First Posted Date: 2015-10-07

Last Posted Date: 2018-01-03

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 1

Registration Number: NCT02569957

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Phase 2

Active, not recruiting

Conditions: Malignant Neoplasm
Indolent Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
Acute Myeloid Leukemia in Remission
Aplastic Anemia
Myeloproliferative Neoplasm
Plasma Cell Myeloma
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome
Hodgkin Lymphoma

Interventions: Drug: Fludarabine
Radiation: Total-Body Irradiation
Biological: T Cell-Depleted Donor Lymphocyte Infusion
Drug: Cyclophosphamide
Procedure: Peripheral Blood Stem Cell Transplantation
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Drug: Tacrolimus
Drug: Mycophenolate mofetil
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-10-02

Last Posted Date: 2023-08-02

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 35

Registration Number: NCT02566304

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Phase 1

Completed

Conditions: Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Carcinoma Metastatic in the Bone
Stage IV Prostate Cancer AJCC v7

Interventions: Drug: Enzalutamide
Drug: Ribociclib
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
Procedure: Biospecimen Collection
Procedure: Biopsy
Procedure: Echocardiography
Procedure: Multigated Acquisition Scan
Procedure: Bone Scan
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging

First Posted Date: 2015-09-21

Last Posted Date: 2024-05-13

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 46

Registration Number: NCT02555189

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

and more 1 locations

Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)

Not Applicable

Completed

Conditions: Head and Neck Carcinoma

Interventions: Dietary Supplement: Dietary intervention

First Posted Date: 2015-09-21

Last Posted Date: 2024-05-03

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 7

Registration Number: NCT02555176

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma

Phase 1

Withdrawn

Conditions: Cutaneous T-Cell Non-Hodgkin Lymphoma
Recurrent Mycosis Fungoides and Sezary Syndrome
Stage IIB Mycosis Fungoides and Sezary Syndrome
Stage IIIA Mycosis Fungoides and Sezary Syndrome
Stage IIIB Mycosis Fungoides and Sezary Syndrome
Stage IVA Mycosis Fungoides and Sezary Syndrome
Stage IVB Mycosis Fungoides and Sezary Syndrome

Interventions: Drug: Fludarabine
Radiation: Total-Body Irradiation
Biological: T Cell-Depleted Donor Lymphocyte Infusion
Drug: Cyclophosphamide
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Procedure: Peripheral Blood Stem Cell Transplantation
Drug: Mycophenolate mofetil
Drug: Tacrolimus

First Posted Date: 2015-09-14

Last Posted Date: 2017-04-19

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Registration Number: NCT02548468

Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer

Not Applicable

Completed

Conditions: Pancreatic Carcinoma

Interventions: Procedure: Pancreaticoduodenectomy

First Posted Date: 2015-08-06

Last Posted Date: 2019-12-19

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 98

Registration Number: NCT02517268

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy